FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Baxter Recalls Spectrum Infusion Pumps

Baxter Healthcare recalls its Sigma Spectrum Infusion Pumps with Master Drug Library and the Baxter Spectrum IQ Infusion Systems with Dose IQ Safety S...

Human Drugs

Genentech Gets New Indication for Xolair

FDA approves a Genentech supplemental BLA for Xolair (omalizumab) for the add-on maintenance treatment of nasal polyps in adult patients having an ina...

Federal Register

Guide on Gastric pH-Dependent Drug Interactions

Federal Register notice: FDA makes available a draft guidance entitled Evaluation of Gastric pH-Dependent Drug Interactions With Acid-Reducing Agents:...

FDA General

Hahn Summoned to White House About Vaccine Delay

President Trumps chief of staff Mark Meadows summons FDA commissioner Stephen Hahn to the White House 12/1 to learn why the agency has not approved or...

Medical Devices

FDA Recognizes A2LA for ASCA Pilot

FDA recognizes A2LA to assess testing laboratories for the Accreditation Scheme for Conformity Assessment pilot program.

Human Drugs

After FDA Meeting, Minerva Continuing Roluperidone Development

Minerva Neurosciences says it believes it can address negative FDA comments about two roluperidone studies through published regulatory guidance and p...

FDA General

Latest FDA Warning Letters

FDA releases its latest batch of Warning Letters that include ForYou Inc. and Industry Lab Diagnostic Partners.

Federal Register

NECC Owner Cadden Barred by FDA

Federal Register notice: FDA issues an order permanently debarring Barry J. Cadden after a conviction in his role as an owner and director of the New ...

Human Drugs

Drug Approved for Rare Forms of Obesity

FDA approves a Rhythm Pharmaceutical NDA for Imcivree (setmelanotide) for chronic weight management in patients six years and older with obesity due t...

Human Drugs

Pilot Program for Novel Drug Development Tools

FDA launches the Innovative Science and Technology Approaches for New Drugs pilot program for novel drug development tool developers.